ArticleMolecular oncology2026

Characterization of therapeutic antibodies targeting lymphatic and vascular resistance factor for the treatment of hypervascularized and highly metastatic cancers.

Marion David et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.